Sakar Healthcare - Quaterly Results

Sakar Healthcare Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 0 | NSE: SAKAR

14 Aug 2023 Evaluate

The Sales for the quarter ended June 2023 of Rs. 389.89 millions rose by 36.64% from Rs. 285.34 millions.The Net Profit of the company registered a slight decline of -1.25% to Rs. 28.42 millions from Rs. 28.78 millions.Operating Profit saw a handsome growth to 105.48 millions from 83.65 millions in the quarter ended June 2023.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202306	202206	% Var	202306	202206	% Var	202303	202203	% Var
Sales	389.89	285.34	36.64	389.89	285.34	36.64	1333.59	1282.27	4.00
Other Income	15.21	4.08	272.79	15.21	4.08	272.79	46.75	21.71	115.34
PBIDT	105.48	83.65	26.10	105.48	83.65	26.10	378.16	315.73	19.77
Interest	20.77	8.59	141.79	20.77	8.59	141.79	59.50	28.97	105.38
PBDT	84.71	75.06	12.86	84.71	75.06	12.86	318.61	286.76	11.11
Depreciation	45.19	35.69	26.62	45.19	35.69	26.62	149.86	96.67	55.02
PBT	39.52	39.37	0.38	39.52	39.37	0.38	168.75	190.09	-11.23
TAX	11.10	10.59	4.82	11.10	10.59	4.82	41.18	37.65	9.38
Deferred Tax	11.10	10.59	4.82	11.10	10.59	4.82	41.18	3.55	1060.00
PAT	28.42	28.78	-1.25	28.42	28.78	-1.25	127.57	152.44	-16.31
Equity	190.40	171.18	11.23	190.40	171.18	11.23	190.40	171.18	11.23
PBIDTM(%)	27.05	29.32	-7.72	27.05	29.32	-7.72	28.36	24.62	15.16